Sodium phosphate, monobasic, unspecified form

Star0

DB14503ApprovedSmall moleculeOsmotic Laxatives

Sodium phosphate, monobasic, unspecified form is an osmotic laxative used to cleanse the colon before a colonoscopy.

Mechanism: Sodium phosphate is thought to work by increasing the amount of solute present in the intestinal lumen thereby creating an osmotic gradient which draws water into the lumen.
Curator reviewed · 1 reference
Primary indication: Used to treat constipation or to clean the bowel before a colonoscopy.Curator reviewed · 2 structured indications
First approval: United States, 2009
Brand names: Fleet Mineral Oil
Pedia-lax Liquid
Urogesic Blue Reformulated Apr 2012

Resolves to

Compound

UNII3980JIH2SW

Transporters

Q8WUM9SLC20A1Q08357SLC20A2Q06495SLC34A1O95436SLC34A2Q8N130SLC34A3

What you can answer from here — as of April 02, 2025

5TransportersSubstrate / inhibitor direction, not just membership

Listed above

413Drug interactionsStructured to mechanism, not free text

2Structured indicationsCondition, population, route and combination as fields, not prose

152Marketed productsAcross 2 countries and 65 labellers

12+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Sodium phosphate, monobasic, unspecified form, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account